Sight Sciences Inc SGHT:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
37.94quote price arrow up+0.56 (+1.50%)
Volume
125,873
52 week range
27.13 - 42.57

...

Loading . . .
  • Open37.74
  • Day High39.70
  • Day Low37.09
  • Prev Close37.38
  • 52 Week High42.57
  • 52 Week High Date08/02/21
  • 52 Week Low27.13
  • 52 Week Low Date07/15/21

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open37.74
  • Day High39.70
  • Day Low37.09
  • Prev Close37.38
  • 52 Week High42.57
  • 52 Week High Date08/02/21
  • 52 Week Low27.13
  • 52 Week Low Date07/15/21
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sight Sciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sight Sciences, Inc. is an ophthalmic medical device company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company’s surgical glaucoma product portfolio features the OMNI surgical system (OMNI), a device that facilitates the performance of both trabeculotomy and canaloplasty with a single device and single corneal incision. Its nonsurgical dry eye product portfolio...
Paul Badawi
Chief Executive Officer
Jesse Selnick
Chief Financial Officer
Ingrid Kane M.D.
Vice President
Address
3000 Sand Hill Road
Building 3, Suite 105
Menlo Park, CA
94025
United States